Amgen Buys Brazilian Drug Firm & Brazilian Drug Rights
By Anette Breindl
Monday, April 11, 2011
Thousand Oaks, Calif.- based biotech giant Amgen Inc. has taken several steps to expand its operations in Brazil: On Friday the company announced it acquired privately held Brazilian drugmaker Bergamo and reacquired the rights to several of its own products in Brazil.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.